CURRICULUM VITAE DR. ALIREZA SHAMSAEEFAR

ABU – ALI SINA CHARITY HOSPITAL 1

Name: Ali-Reza

Surname: Shamsaeefar

Sex: Male

Marital Status: Married

Nationality: Iranian

Birth place: Esfahan, Iran.

Birth Date: 25.7.1969

Email: shamsaeefar@yahoo.com

Address: Shiraz Organ Transplant Center, Avicenna Hospital, Shiraz University of

Medical Sciences, No 985, Boostan Blvd, Pasdaran Blvd, Sadra New City,

Shiraz 71994-67985, Iran

Tel: +98-71-3344-1701

Email: shamsaeefar@yahoo.com

Organ Transplantation and Hepato – Pancerato Biliary Surgeon

Personal Background

Current Position

CURRICULUM VITAE DR. ALIREZA SHAMSAEEFAR

ABU – ALI SINA CHARITY HOSPITAL 2

2009-2011: Transplant fellowship, Shiraz University of Medical Sciences,

Shiraz, Iran;

2000- 2005: Specialty in Surgery, Shiraz University of Medical Sciences, Shiraz, Iran;

1988-1995: Medical Doctor, Esfahan University of Medical Sciences, Esfahan, Iran;

1984-1990: High School, Harati High school, Esfahan, Iran;

1979-1984: Elementary School, Farabi School, Esfahan, Iran.

2011 up to now: Fellow of Transplant Surgery, Shiraz University of Medical Sciences

2009 -2011: Fellow of Transplant surgery, Shiraz University of Medical Sciences,

Shiraz, Iran

2008-2009: General Surgeon, Shahid-Mohamadi Hospital, Hormozgan Medical

Sciences, Hormozgan Iran

2006-2008: General Surgeon, Nabiakram hospital, Khong, Shiraz University of

Medical Sciences, Iran.

1995-2000: General Practitioner, Fasa health and treatment network, Fasa University

of Medical Sciences, Iran.

Educations

Personal Activities

CURRICULUM VITAE DR. ALIREZA SHAMSAEEFAR

ABU – ALI SINA CHARITY HOSPITAL 3

Membership in Scientific Societies as fallow:

Member of the Iranian Medical Council;

Member of the Iranian Association of General Surgeons;

Member of the Iranian transplant Association.

1. Exp Clin Transplant. 2012 Aug; 10(4):307-9.

Clinical experience in organ transplant from the Shiraz Transplant Center: 2011.

Nikeghbalian S1, Aliakbarian M, Kazemi K, Shamsaeefar A, Salehipour M, Bahreini A,

Mehdi SH, Salahi H, Bahador A, Malekhossein SA.

Shiraz University of Medical Sciences, Shiraz, Iran.

2. EXCLI J. 2019 Aug 22; 18:666-676. Doi: 10.17179/excli2019-1698. ECollection 2019.

Cytoprotective effects of ginsenoside Rd on apoptosis-associated cell death in the

isolated human pancreatic islets.

Kaviani M1, Keshtkar S1,2, Azarpira N1, Hossein Aghdaei M1, Geramizadeh B1, Karimi

MH1, Yaghobi R1, Esfandiari E1, Shamsaeefar A3, Nikeghbalian S3, Al-Abdullah

IH4.

3. Clin Res Hepatol Gastroenterol. 2019 Oct 11. Pii: S2210-7401(19)30216-5. Doi:

10.1016/j.clinre.2019.09.002.

Characterization of biopsy proven non-alcoholic fatty liver disease in healthy non-

obese and lean population of living liver donors: The impact of uric acid.

Eshraghian A1, Nikeghbalian S2, Geramizadeh B2, Kazemi K2, Shamsaeefar A2, Malek-

Hosseini SA2.

Membership

Publications

CURRICULUM VITAE DR. ALIREZA SHAMSAEEFAR

ABU – ALI SINA CHARITY HOSPITAL 4

4. Exp Clin Transplant. 2019 Oct 1. Doi: 10.6002/ect.2019.0205.

Nonalcoholic Steatohepatitis Is the Most Rapidly Growing Indication for Liver

Transplantation in Iranian Patients.

Eshraghian A1, Nikeghbalian S, Dehghani M, Shamsaeefar A, Kazemi K, Nikoopour H,

Eghlimi H, Gholami S, Salahi H, Malek-Hosseini SA.

5. Int J Organ Transplant Med. 2019; 10(3):108-113.

The Effects of Cold Preservation Solutions Supplemented with UDCA and α-Lipoic

Acid on the Viability and Function of Isolated Human Hepatocytes.

Hossein Aghdaie M1, Azarpira N1, Esfandiari E1, Kaviani M1, Golbabapour S1,

Shamsaeefar A2, Kazemi K2, Dehghani M2, Bahador A2, Salahi H2, Nikeghbalian S2,

Malek-Hosseini SA2, Geramizadeh B1,3.

6. HPB (Oxford). 2019 Aug 17. Pii: S1365-182X (19)30634-3. Doi:

10.1016/j.hpb.2019.07.015.

Non-alcoholic fatty liver disease after liver transplantation in patients with non-

alcoholic steatohepatitis and cryptogenic cirrhosis: the impact of pre-transplant

graft Steatosis.

Eshraghian A1, Nikeghbalian S2, Kazemi K2, Shamsaeefar A2, Geramizadeh B2, Malek-

Hosseini SA2.

7. Sci Rep. 2019 Aug 12; 9(1):11701. Doi: 10.1038/s41598-019-48262-6.

Protective effect of nobiletin on isolated human islets survival and function against

hypoxia and oxidative stress-induced apoptosis.

Keshtkar S1, Kaviani M2, Jabbarpour Z1, Geramizadeh B2, Motevaseli E1, Nikeghbalian

S3, Shamsaeefar A3, Motazedian N2, Al-Abdullah IH4, Ghahremani MH5,6, Azarpira

N7,8.

8. Exp Clin Transplant. 2019 Jul 2. Doi: 10.6002/ect.2019.0089.

Hepatic Computed Tomography Volumetry for Noninvasive Detection of Hepatic

Steatosis and Steatohepatitis in Living Liver Donors.

Eshraghian A1, Rasekhi A, Nikeghbalian S, Muhammad S, Kazemi K, Jalaeian H,

Shamsaeefar A, Geramizadeh B, Malek-Hosseini SA.

9. Eur J Pharmacol. 2019 Sep 5; 858:172518. Doi: 10.1016/j.ejphar.2019.172518. Epub

2019 Jun 29.

Amelioration of the apoptosis-mediated death in isolated human pancreatic islets by

minocycline.

Kaviani M1, Keshtkar S2, Azarpira N3, Aghdaei MH1, Geramizadeh B1, Karimi MH1,

Shamsaeefar A4, Motazedian N1, Nikeghbalian S4, Al-Abdullah IH5.

10. J Gastrointest Cancer. 2019 Apr 27. Doi: 10.1007/s12029-019-00244-7.

CURRICULUM VITAE DR. ALIREZA SHAMSAEEFAR

ABU – ALI SINA CHARITY HOSPITAL 5

Liver Transplantation for High-Grade Primary Hepatic Neuroendocrine Tumor with

Diffuse Liver Metastasis.

Nikeghbalian S1, Eshraghian A2, Kazemi K1, Shamsaeefar A1, Hosseinzadeh M3,

Geramizadeh B3, Malek-Hosseini SA1.

11. Biomed Pharmacother. 2019 Apr; 112:108674. Doi: 10.1016/j.biopha.2019.108674.

Epub 2019 Feb 19.

Cytoprotective effects of olesoxime on isolated human pancreatic islets in order to

attenuate apoptotic pathway.

Kaviani M1, Keshtkar S2, Azarpira N3, Aghdaei MH1, Geramizadeh B1, Karimi MH1,

Shamsaeefar A4, Motazedian N1, Nikeghbalian S4, Al-Abdullah IH5, Ghahremani

MH6.

12. Int J Clin Pract. 2018 Dec 28:e13309. Doi: 10.1111/ijcp.13309.

Portal vein thrombosis in patients with liver cirrhosis and its impact on early and

long-term outcomes after liver transplantation.

Eshraghian A1, Nikeghbalian S1, Kazemi K1, Mansoorian M1, Shamsaeefar A1, Eghlimi

H1, Gholami S1, Salahi H1, Malek-Hosseini SA1.

13. Arch Iran Med. 2018 Jul 1; 21(7):275-282.

Liver Transplantation Status in Iran: A Multi-center Report on the Main Transplant

Indicators and Survival Rates.

Malek-Hosseini SA1, Jafarian A2, Nikeghbalian S1, Poustchi H3, Lankarani KB1, Nasiri

Toosi M2, Salahi H1, Dehghani M1, Eshraghian A1, Sharafkhah M3, Eghtesad S3,

Motamed-Gorji N3, Kazemi K1, Salimi J2, Moini M2, Shamsaeefar A1, Moini M1,

Dehghani M4, B Khosravi M1, Najafi A2, Sattari H4, Geramizadeh B1, Shafiee M4,

Toutouni MN5, Sanei B6, Nejatollahi SM7, Taghavi A1, Bahador A1, Aliakbarian M5,

Eghtesad B8, Malekzadeh R3.

14. Exp Clin Transplant. 2018 Jul 11. Doi: 10.6002/ect.2017.0246.

Retransplant of the Liver: 12-Year Experience of the Shiraz Organs Transplantation

Center.

Shamsaeefar A1, Saleh T, Kazemi K, Nikeghbalian S, Dehghani M, Mansurian M,

Gholami S, Khosravi B, Malek Hosseini SA.

15. Exp Clin Transplant. 2018 Apr 20. Doi: 10.6002/ect.2017.0110.

Single Center Long-Term Results of Pediatric Liver Transplantation.

Al Sayyed MH1, Shamsaeefar A, Nikeghbalian S, Dehghani SM, Bahador A, Dehghani

M, Rasekh R, Gholami S, Khosravi B, Malek Hosseini SA.

16. Clin Transplant. 2018 May; 32(5):e13241. Doi: 10.1111/ctr.13241. Epub 2018 Apr 6.

CURRICULUM VITAE DR. ALIREZA SHAMSAEEFAR

ABU – ALI SINA CHARITY HOSPITAL 6

University of Wisconsin vs normal saline solutions for preservation of blood vessels

of brain dead donors: A histopathological study.

Kazemi K1, Nikeghbalian Z1, Yaghmaei S2, Nikeghbalian S1, Shamsaeefar A1, Asgharnia

Y3, Dehghankhalili M4, Golchini A2, Malekhosseini SA1

18. Prog Transplant. 2017 Jun; 27(2):192-195. Doi: 10.1177/1526924817699964. Epub

2017 Mar 22.

Thirteen-Year Evaluation of the Management of Biliary Tract Complication after

Deceased Donor Liver Transplantation.

Shamsaeefar A1, Nikeghbalian S1, Kazemi K1, Motazedian N2, Geramizadeh B2,

Malekhosseini SA1.

19. Exp Clin Transplant. 2019 Apr; 17(2):263-265. Doi: 10.6002/ect.2016.0158. Epub

2017 Apr 14.

Kidney Transplant from a Deceased Donor with Renal Artery Aneurysm: A Case

Report.

Shamsaeefar A1, Nikeghbalian S, Kazemi K, Mansorian M, Motazedian N,

Malekhosseini SA.

20. Clin Transplant. 2017 Jun; 31(6). Doi: 10.1111/ctr.12964. Epub 2017 Apr 19.

Biliary reconstruction in liver transplant patients with primary sclerosing

cholangitis, duct-to-duct or Roux-en-Y?

Shamsaeefar A1, Shafiee M1, Nikeghbalian S1, Kazemi K1, Mansorian M1, Motazedian

N2, Afshinnia F3, Geramizadeh B2, Malekhosseini SA1.

21. World J Gastroenterol. 2017 Feb 21; 23(7):1224-1232. Doi: 10.3748/wjg.v23.i7.1224.

Post-transplant lymphoproliferative disorder after liver transplantation: Incidence,

long-term survival and impact of serum tacrolimus level.

Eshraghian A1, Imanieh MH1, Dehghani SM1, Nikeghbalian S1, Shamsaeefar A1,

Barshans F1, Kazemi K1, Geramizadeh B1, Malek-Hosseini SA1.

22. Exp Clin Transplant. 2017 Feb; 15(Suppl 1):269-272.

Impact of a Full-Time Donor Management Protocol on Donors' Liver Biopsy

Findings: Progress to Date.

Mojtabaee M1, Shamsaeefar A, Gholami S, Mohsenzadeh M, Sadegh Beigee F.

23. Exp Clin Transplant. 2018 Apr; 16(2):177-181. Doi: 10.6002/ect.2016.0129. Epub

2017 Feb 7.

Experience of Liver Transplant in Patients Diagnosed with Budd-Chiari Syndrome.

Raza SM1, Zainab S, Shamsaeefar AR, Nikeghbalian S, Malek Hosseini SA.

24. Hepat Mon. 2016 Oct 8; 16(10):e40140. ECollection 2016 Oct.

CURRICULUM VITAE DR. ALIREZA SHAMSAEEFAR

ABU – ALI SINA CHARITY HOSPITAL 7

Transplantation of Deceased Donor Livers with Elevated Levels of Serum

Transaminases at Shiraz Transplant Center.

Fakhar N1, Nikeghbalian S1, Kazemi K1, Shamsayeefar AR1, Gholami S1, Kasraianfard

A2, Malek-Hosseini SA1.

Exp Clin Transplant. 2019 Feb; 17(1):119-120. Doi: 10.6002/ect.2016.0052. Epub 2016 Jul

22.

Curative Treatment of Ornithine Transcarbamylase Deficiency with a Liver

Transplant: A Case Report.

Shamsaeefar A1, Nikeghbalian S, Dehghani SM, Kazemi K, Motazedian N,

Geramizadeh B, Malekhosseini SA.

25. Saudi J Kidney Dis Transpl. 2016 Jul-Aug; 27(4):665-70. Doi: 10.4103/1319-

2442.185221.

Effects of induction therapy with alemtuzumab versus antithymocyte globulin

among highly sensitized kidney transplant candidates.

Shamsaeefar A1, Roozbeh J2, Khajerezae S1, Nikeghbalian S1, Kazemi K1, Motazedian

N3, Geramizadeh B3, Malekhosseini SA1.

26. Pediatr Transplant. 2015 Sep; 19(6):605-11. Doi: 10.1111/petr.12562.

Liver transplantation as a definitive treatment for familial hypercholesterolemia: A

series of 36 cases.

Mansoorian M1, Kazemi K1, Nikeghbalian S1, Shamsaeefar A1, Mokhtari M2, Dehghani

SM3, Bahador A1, Salahi H1, Amoozgar H4, Malek Hosseini SA1.

27. Liver Transpl. 2015 May; 21(5):696-9. Doi: 10.1002/lt.24095.

Liver transplantation and Whipple surgery combined with chemoradiotherapy for

treatment of hilar cholangiocarcinoma in patients with primary sclerosing

cholangitis.

Nikeghbalian S1, Shamsaeefar A, Eshraghian A, Mansoorian MR, Kazemi K,

Geramizadeh B, Malek-Hosseini SA.

28. Exp Clin Transplant. 2015 Oct; 13(5):426-9. Doi: 10.6002/ect.2013.0193. Epub 2014

Sep 17.

Prevention of Post-transplant Lymphoproliferative Disorder in Pediatric Patients

with a Liver Transplant.

Aliakbarian M1, Dehghani SM, Geramizadeh B, Nikeghbalian S, Kasiri K, Kazemi K,

Shamsaeefar A, Bahador A, Malekhosseini SA.

29. Arch Iran Med. 2014 Sep; 17(9):640-1. Doi: 0141709/AIM.0012.

En-bloc liver-pancreas transplant in Iran.

CURRICULUM VITAE DR. ALIREZA SHAMSAEEFAR

ABU – ALI SINA CHARITY HOSPITAL 8

Nikeghbalian S1, Mehdi SH2, Aliakbarian M3, Kazemi K2, Shamsaeefar A2, Bahreini A2,

Gholami S2, Malekhosseini SA3.

30. Int J Organ Transplant Med. 2014; 5(3):120-4.

Ex-vivo Resection and Small-Bowel Auto-transplantation for the Treatment of

Tumors at the Root of the Mesentery.

Nikeghbalian S1, Aliakbarian M2, Kazemi K1, Shamsaeefar AR1, Mehdi SH1, Bahreini

A1, Malek-Hosseini SA1.

31. Int J Organ Transplant Med. 2014; 5(2):59-65.

Multivisceral and small bowel transplantation at Shiraz organ transplant center.

Nikeghbalian S1, Mehdi SH1, Aliakbarian M2, Kazemi K1, Shamsaeefar A1, Bahreini A1,

Mansoorian MR1, Malekhosseini SA1.

32. Int J Organ Transplant Med. 2014; 5(1):34-7.

Shiraz guideline for the management of patients with brain death.

Firoozifar M1, Khosravi MB1, Ghafari S1, Sahmeddini MA1, Eghbal H1, Salahi H1,

Bahador A1, Nikeghbalian S1, Kazemi K1, Shamsaeefar AR1, Gholami S1, Farhadi E1,

Shahnazi MA1, Malek-Hosseini SA1.

33. Exp Clin Transplant. 2016 Feb; 14(1):93-5. Doi: 10.6002/ect.2013.0260. Epub 2014

Jun 9.

Nutcrackerlike Phenomenon Is An Unusual Cause for Gross Hematuria After a

Kidney Graft.

Salehipour M1, Kazemi K, Shamsaeefar A, Hekmati P, Sanaei AK, Bahador A,

Aliakbarian M, Malek Hosseini SA.

34. Exp Clin Transplant. 2016 Apr; 14(2):235-7. Doi: 10.6002/ect.2013.0277. Epub 2014

Jun 9.

Modified Multivisceral Transplant After Acute Abdominal Trauma.

Nikeghbalian S1, Alaa Eldin A, Aliakbarian M, Kazemi K, Shamsaeefar A, Gholami S,

Malekhosseini SA.

35. Exp Clin Transplant. 2015 Apr;13(2):163-6. doi: 10.6002/ect.2013.0135. Epub 2014

May 19.

De novo malignancy after liver transplant.

Sanaei AK1, Aliakbarian M, Kazemi K, Nikeghbalian S, Shamsaeefar A, Mehdi SH,

Bahreini A, Dehghani SM, Geramizadeh B, Malekhosseini SA.

36. Exp Clin Transplant. 2014 Mar; 12 Suppl 1:178-81.

Discarded organs at Shiraz Transplant Center.

CURRICULUM VITAE DR. ALIREZA SHAMSAEEFAR

ABU – ALI SINA CHARITY HOSPITAL 9

Shamsaeefar A1, Nikeghbalian S, Kazemi K, Mansorian M, Gholami S, Motazedian N,

Malekhosseini SA.

37.Transplant Proc. 2013; 45(10):3528-30. Doi: 10.1016/j.transproceed.2013.09.002.

Multivisceral transplantation for the treatment of intra-abdominal tumors.

Nikeghbalian S1, Aliakbarian M, Shamsaeefar A, Kazemi K, Bahreini A, Malekhosseini

SA.

38. Arch Iran Med. 2013 Jun; 16(6):348-50. Doi: 013166/AIM.008.

Hepatocellular carcinoma in explanted livers of patients with genotype d HBV

cirrhosis: report of the first experience from Iran.

Geramizadeh B1, Nikeghbalian S, Kazemi K, Shamsaifar A, Bahador A, Salahi H,

Malekhosseini SA, Kashtkar Jahromi M, Bakhshai Dehkordi A.

39. Exp Clin Transplant. 2012 Aug; 10(4):307-9.

Clinical experience in organ transplant from the Shiraz Transplant Center: 2011.

Nikeghbalian S1, Aliakbarian M, Kazemi K, Shamsaee far A, Salehipour M, Bahreini A,

Mehdi SH, Salahi H, Bahador A, Malekhossein SA.

40. Int J Organ Transplant Med. 2012; 3(3):111-4.

En-bloc Transplantation: an Eligible Technique for Unilateral Dual Kidney

Transplantation.

Salehipour M1, Bahador A1, Nikeghbalian S1, Kazemi K1, Shamsaeifar AR1,

Ghaffaripour S1, Sahmeddini MA1, Salahi H1, Bahreini A1, Janghorban P1, Gholami

S1, Malek-Hosseini SA1.

41. Int J Organ Transplant Med. 2010; 1(4):189-92.

The first modified Multivisceral transplantation in the Middle East: a major advance

in transplantation surgery in Shiraz transplant center.

Nikeghalian S1, Davari HR1, Kakaei F1, Shamsaeefar A1, Sanei B1, Geramizadeh B1,

Moini M1, Sahmeddini MA1, Malek-Hosseini SA1.

42. Int J Organ Transplant Med. 2010; 1(1):44-8. Epub 2010 Feb 1.

Liver transplantation in the presence of old portal vein thrombosis.

Kakaei F1, Nikeghbalian S1, Salahi H1, Bahador A1, Kazemi K1, Dehghani M1,

Shamsaeefar A1, Sanei B1, Ghaffaripour S1, Rajaei E1, Gholami S1, Malek-Hosseini

SA1.

43. Transplant Proc. 2009 Sep; 41(7):2939-41. Doi: 10.1016/j.transproceed.2009.07.028.

Liver transplantation for homozygous familial hypercholesterolemia: two case

reports.

CURRICULUM VITAE DR. ALIREZA SHAMSAEEFAR

ABU – ALI SINA CHARITY HOSPITAL 10

Kakaei F1, Nikeghbalian S, Kazemi K, Salahi H, Bahador A, Dehghani SM, Dehghani

M, Nejatollahi SM, Shamsaeefar A, Khosravi MB, Malek-Hosseini SA.

44. Transplant Proc. 2009 Sep; 41(7):2729-30. Doi: 10.1016/j.transproceed.2009.07.029.

Transperitoneal laparoscopic living donor nephrectomy: 2 years' experience.

Nikeghbalian S1, Kazemi K, Salehipour M, Roozbeh J, Sagheb MM, Kakaei F, Dehghani

M, Shamsaeefar A, Ghaffaripour S, Banihashemi SJ, Malek-Hosseini SA.

45. Liver transplantation for homozygous familial hypercholesterolemia: two case

reports

…, M Dehghani, SM Nejatollahi, A Shamsaeefar… - Transplantation …, 2009 - Elsevier

Homozygous familial hypercholesterolemia (HFHC) is a rare inherited condition with

an

incidence of one in one million. It is associated with severe premature

atherosclerosis and

early death from cardiovascular complications. Mutation in the gene that encodes

the …

46. Liver transplantation as a definitive treatment for familial hypercholesterolemia:

a series of 36 cases

…, S Nikeghbalian, A Shamsaeefar… - Pediatric …, 2015 - Wiley Online Library

FH is a genetic disorder characterized by an increase in serum LDL and total

cholesterol

values. The afflicted patients are at increased risk of premature atherosclerosis and

myocardial infarction. Different treatment modalities are present, including

pharmacological …

47. Multivisceral transplantation for the treatment of intra-abdominal tumors

S Nikeghbalian, M Aliakbarian, A Shamsaeefar… - Transplantation …, 2013 - Elsevier

Background some intra-abdominal or retroperitoneal tumors such as low-grade slow-

growing malignancies may seem unrespectable due to major vessel encasement or

presence

of intra-abdominal dissemination, but the slow growth rate and to some extent

long life …

48. Post-transplant lymphoproliferative disorder after liver transplantation:

Incidence, long-term survival and impact of serum tacrolimus level

…, S Nikeghbalian, A Shamsaeefar… - World journal of …, 2017 - ncbi.nlm.nih.gov

21` METHODS A cross-sectional survey was

cond ucted among patients who underwent liver transplantation at Shiraz

Transplant Center …

CURRICULUM VITAE DR. ALIREZA SHAMSAEEFAR

ABU – ALI SINA CHARITY HOSPITAL 11

49. Ex-vivo resection and small-bowel auto-transplantation for the treatment of

tumors at the root of the mesentery

…, K Kazemi, AR Shamsaeefar… - … journal of organ …, 2014 - ncbi.nlm.nih.gov

Background: Tumors involving the root of the mesentery are generally regarded as

“unresectable” with conventional surgical techniques. Resection with conventional

surgery

may end in life-threatening complications in these patients. Ex-vivo resection and

auto …

50. Transperitoneal laparoscopic living donor nephrectomy: 2 years' experience

…, F Kakaei, M Dehghani, A Shamsaeefar… - Transplantation …, 2009 - Elsevier

Background Due to the shortage of organ donations and the rising number of patients

with

terminal renal insufficiency, living donor kidney donation has become

increasingly important

during recent years. Hand-assisted laparoscopic living donor nephrectomy

(LLDN) is an …

51. De novo malignancy after liver transplant

…, K Kazemi, S Nikeghbalian, A Shamsaeefar… - Exp Clin …, 2015 - researchgate.net

Objectives: Patients who have liver transplant are at high risk of developing de novo

malignancies. The purpose of this study was to evaluate incidence and histologic

type of de

novo malignancies after liver transplant in a liver transplant center. Materials and

Methods …

52. Liver transplantation and whipple surgery combined with chemoradiotherapy

for treatment of hilar cholangiocarcinoma in patients with primary sclerosing …

S Nikeghbalian, A Shamsaeefar… - Liver …, 2015 - Wiley Online Library

DISCUSSION Herein, we describe 4 PSC patients with hilar CC treated with OLT–

Whipple

surgery combined with chemoradiotherapy. Patients with confirmed hilar CC

were explored

for regional and distant metastasis before OLT. One of our patients remained

tumor-free for 3 …

53. Bowel perforation by crumpled paper in a patient presenting with acute

abdominal pain

…, SMV Hosseini, T Razmi, A Shamsaeefar - Saudi journal of …, 2009 -

ncbi.nlm.nih.gov

CURRICULUM VITAE DR. ALIREZA SHAMSAEEFAR

ABU – ALI SINA CHARITY HOSPITAL 12

Many of the abdominal foreign bodies are due to accidental ingestion. Our objective in

this

case report is to emphasize the importance of the enquiry about the foreign body

in the

differential diagnosis of acute abdominal pain. According to our knowledge, this is

the first …

54. Cholangiocarcinoma Secondary to Primary Sclerosing Cholangitis in Explanted

Livers: A Single-Center Study in the South of Iran

…, R Ghavvas, K Kazemi, A Shamsaeefar… - Hepatitis …, 2015 - ncbi.nlm.nih.gov

Background: Primary sclerosing cholangitis (PSC) is a chronic disease, characterized by

chronic inflammation and fibrosis of bile duct epithelial cells. This is a significant

contributory

factor to the development of malignancy, most commonly cholangiocarcinoma

(CCA), which …